| 01/15 | NOVARTIS : Deutsche Bank Starts Novartis at Buy | MT |
| 01/15 | NOVARTIS AG : Gets a Buy rating from Deutsche Bank | MD |
| 01/15 | NOVARTIS : Exane BNP Paribas Lowers Price Target on Novartis, Maintains Outperfo.. | MT |
| 01/14 | Invitae to Develop Standardized Panel to Detect Molecular Residual Disease as.. | MT |
| 01/14 | NOVARTIS : Gets FDA Breakthrough-Therapy Designation for Ligelizumab | DJ |
| 01/14 | NOVARTIS AG : UBS maintains a Buy rating | MD |
| 01/14 | NOVARTIS' : Ligelizumab Receives FDA Breakthrough Therapy Designation for Urtica.. | MT |
| 01/14 | NOVARTIS : Skin Disease Treatment Ligelizumab Gets US FDA's Breakthrough Therapy.. | MT |
| 01/14 | NOVARTIS : Court Rejects Attempt To "Stretch" Patent Claim Language | AQ |
| 01/14 | NOVARTIS : ligelizumab (QGE031) receives FDA Breakthrough Therapy designation fo.. | PU |
| 01/13 | NOVARTIS AG : Gets a Sell rating from JP Morgan | MD |
| 01/13 | NOVARTIS : Prosecution History Cannot Be Invoked Against Patent Licensees | AQ |
| 01/12 | Novartis, once wary of Chinese M&A, dives into BeiGene's cancer immunotherapy | RE |
| 01/12 | TWITTER, TESLA, REALTY INCOME : What to Watch When the Stock Market Opens Today | DJ |
| 01/12 | TWITTER, TESLA, REALTY INCOME, CANTE : What to Watch When the Stock Market Opens.. | DJ |
| 01/12 | BeiGene Shares Surge 14% on $650 Million Drug Licensing Deal with Novartis | MT |
| 01/11 | Novartis Signs In-License Deal for Tumor Drug Tislelizumab With BeiGene | MT |
| 01/11 | BEIGENE : Novartis partner to develop cancer drug tislelizumab | RE |
| 01/11 | BeiGene to Collaborate With Novartis on Tislelizumab, Will Get $650 Million U.. | DJ |
| 01/11 | BEIGENE : Strikes Licensing Deal With Novartis On Tislelizumab, Gets $650 Millio.. | MT |
| 01/11 | PRESS RELEASE : Novartis expands Oncology pipeline with in-licensing of tisleliz.. | DJ |
| 01/11 | NOVARTIS : expands Oncology pipeline with in-licensing of tislelizumab from BeiG.. | DJ |
| 01/11 | BioNTech lifts 2021 COVID-19 vaccine output target to 2 billion doses | RE |
| 01/11 | BioNTech lifts vaccine target to 2 bln doses | RE |
| 01/11 | BioNTech lifts 2021 COVID-19 vaccine output target to 2 bln doses | RE |
| 01/11 | NOVARTIS : Federal Court Clarifies Admissibility Of Prosecution History Evidence.. | AQ |
| 01/11 | EQS-NEWS : Relief, NeuroRx and Quantum Leap announce the inclusion of ZYESAMI(TM.. | DJ |
| 01/08 | NOVARTIS AG : Buy rating from Morgan Stanley | MD |
| 01/08 | NOVARTIS : Morgan Stanley Lifts Price Target on Novartis, Maintains Overweight/I.. | MT |
| 01/07 | WERNER LANTHALER : Evotec to attend upcoming investor conferences | DJ |
| 01/05 | PRESS RELEASE : Evotec achieves milestone in its neurodegeneration collaboration.. | DJ |
| 01/04 | SIEGFRIED : Completes Purchase of Two Novartis Sites in Spain | MT |
| 01/04 | NOVARTIS AG : Sell rating from JP Morgan | MD |
| 01/03 | NOVARTIS : In Canada, shippers race to move cancer treatments as COVID-19 ground.. | RE |
| 2020 | EXPLAINER : How does AstraZeneca's vaccine compare with Pfizer-BioNTech? | RE |
| 2020 | How does AstraZeneca's vaccine compare with Pfizer-BioNTech? | RE |
| 2020 | EXPLAINER : How does AstraZeneca's vaccine compare with Pfizer-BioNTech? | RE |
| 2020 | NOVARTIS : Chairman to Take COVID-19 Vaccine, Acquires Drug Licenses for Treatme.. | MT |
| 2020 | SIEGFRIED : Issues $90 Million Convertible Bonds to Fund Novartis Site Purchase .. | MT |
| 2020 | Drugmakers agree to halve prices to get on China state insurance list | RE |
| 2020 | NOVARTIS : Strict 45-Day Time Limit For Starting PMNOC Action Was Suspended By C.. | AQ |
| 2020 | Regenxbio Sells Royalty Rights to Genetic Therapy Medication for $200 Million.. | MT |
| 2020 | NOVARTIS AG : Goldman Sachs remains its Buy rating | MD |
| 2020 | PRESS RELEASE : Evotec partners with alloy therapeutics to expand its antibody d.. | DJ |
| 2020 | NOVARTIS : Says US FDA Raised No Concerns Over Safety, Efficacy of Cholesterol D.. | MT |
| 2020 | U.S. FDA declines approval of Novartis' cholesterol-lowering drug | RE |
| 2020 | NOVARTIS : U.S. FDA declines approval of Novartis' cholesterol-lowering drug | RE |
| 2020 | PRESS RELEASE : Novartis receives complete -2- | DJ |
| 2020 | PRESS RELEASE : Novartis receives complete response letter from U.S. FDA for inc.. | DJ |
| 2020 | NOVARTIS : receives complete response letter from U.S. FDA for inclisiran | DJ |
| 2020 | UPDATE : Mesoblast Says Remestemcel-L Not Likely to Meet Primary Endpoint in COV.. | MT |
| 2020 | MESOBLAST : Says Remestemcel-L Not Likely to Meet Primary Endpoint in COVID-19 S.. | MT |
| 2020 | NOVARTIS : Unit Sandoz Gets Canadian Regulatory Nod for Biosimilar Hyrimoz | MT |
| 2020 | Health Care Up As Moderna Gains On Vaccine Approval Prospects -- Health Care .. | DJ |
| 2020 | EUROPE : European shares up for fourth session on stimulus, vaccine optimism | RE |
| 2020 | GLOBAL MARKETS LIVE: Tech giants in the midst of controversy | |
| 2020 | NOVARTIS : investigational oral therapy iptacopan receives FDA Breakthrough Ther.. | AQ |
| 2020 | ETF PREVIEW : ETFs, Futures Remain in the Green on Vaccine, Stimulus Optimism; W.. | MT |
| 2020 | NOVARTIS : to Acquire Cadent Therapeutics for Up to $770 Million | MT |
| 2020 | NOVARTIS : buys neuroscience company Cadent for up to $770 million | RE |
| 2020 | NOVARTIS : Bank Vontobel Lifts Price Target on Novartis, Maintains Hold Recommen.. | MT |
| 2020 | NOVARTIS : to Acquire Neuroscience Company Cadent for Up to $770 Million | DJ |
| 2020 | NOVARTIS : builds on commitment to addressing need in neuropsychiatric disorders.. | PU |
| 2020 | PRESS RELEASE : Evotec achieves key milestones in its collaboration with bristol.. | DJ |
| 2020 | NOVARTIS' : Iptacopan Treatment Gets US FDA Designations in Blood, Renal Disease.. | MT |
| 2020 | NOVARTIS : reports positive topline results from second Phase III trial of Beovu.. | AQ |
| 2020 | NOVARTIS : announces positive FDA Advisory Committee recommendation for use of E.. | AQ |
| 2020 | GLOBAL MARKETS LIVE : Moderna, Google, Twitter…. | |
| 2020 | ETF PREVIEW : ETFs, Futures Point Higher as Distribution of COVID-19 Vaccine Beg.. | MT |
| 2020 | NOVARTIS' : Iptacopan Obtains FDA Breakthrough, Rare Pediatric Disease Designati.. | MT |
| 2020 | NOVARTIS : Wins FDA Committee Recommendation For Entresto To Treat Diastolic Hea.. | MT |
| 2020 | NOVARTIS : investigational oral therapy iptacopan (LNP023) receives FDA Breakthr.. | PU |
| 2020 | NOVARTIS : gets FDA Breakthrough Therapy tag for experimental iptacopan | RE |
| 2020 | NOVARTIS' : Entresto Treatment in Heart Failure Patients Gets US FDA Advisory Re.. | MT |
| 2020 | PRESS RELEASE : Novartis announces positive FDA -2- | DJ |
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
